Table 2: Comparison of Laboratory findings between the intervention (convalescent plasma) group and the control (dexamethasone) group at baseline.

Hematological parameters, value

(95% CI)

Control group

(N = 50)

Convalescent plasma

(N = 28)

p-value

Haemoglobin, mmol/L

7.7

(7.1 – 8.4)

7.3

(6.7 – 8.1)

.26

Hematocrit, %

37

(34 – 40)

36

(33 – 40)

.81

Leukocytes, x 109/L

10.8

(7.7 – 14.8)

10.6

(7.0 – 16.2)

.76

Lymphocytes, x 109/L

1.1

(0.8 – 1.7)

1.0

(0.8 – 1.4)

.49

Thrombocytes, x 109/L

220

(177 – 309)

242

(190 – 322)

.52

C-reactive protein, mg/L

14.3

(5.5 – 22.2)

16.4

(6.4 – 31.2)

.26

Ferritin, mcg/L

1192

(679 – 1502)

1502

(704 – 1502)

.20

D-Dimer, mg/L

225

(139 – 668)

333

(124 – 1060)

.59

Fibrinogen, g/L

5.4

(4.4 – 6.5)

5.7

(5.0 – 6.9)

.12

APTT, sec

36.0

(32.9 – 40.8)

36.2

(29.0 – 40.2)

.47

Creatinine, mol/L

97

(70 – 129)

82

(63 – 117)

.08

Aspartate aminotransferase, U/L

42

(30 – 66)

50

(30 – 69)

.77

Alanine aminotransferase, U/L

42

(25 – 56)

41

(31 – 54)

.96

Lactate dehydrogenase, U/L

357

(260 – 443)

336

(268 – 460)

.77

Creatin Kinase, U/L

127

(64 – 343)

210

123 – 474)

0.08

APTT: Activated Partial Thromboplastin Time.